EMA Authorised: Bildyos (denosumab) — Sciencepharma Sp. z o.o

View source ↗

Summary

The EMA has authorised Bildyos (denosumab) by Sciencepharma Sp. z o.o. for bone resorption disorders including osteoporosis, including postmenopausal osteoporos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Resorption Disorders
• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• Bildyos (denosumab)

Snippet

Status: Authorised. Therapeutic area: Bone Resorption;Osteoporosis, Postmenopausal;Osteoporosis. MAH: Sciencepharma Sp. z o.o. Decision date: 13/07/2026